{"title":"From Precision Medicine to the Morgue: Translating Pharmacogenomic Knowledge into Forensic Toxicology Practice.","authors":"Kezia Jobi, Sharlize Pedroza Matute, Sasitaran Iyavoo","doi":"10.1093/jat/bkag100","DOIUrl":"https://doi.org/10.1093/jat/bkag100","url":null,"abstract":"<p><p>Pharmacogenomics (PGx) demonstrates how inherited genetic variation can influence drug metabolism, exposure and response, but its application in forensic toxicology remains comparatively underdeveloped. This review examines how clinical pharmacogenomic knowledge may be translated into postmortem toxicological interpretation, particularly where measured drug concentrations do not fully explain the circumstances of death. Conventional interpretation is complicated by interindividual variability, postmortem redistribution, tolerance, polypharmacy and drug interactions. Genetic variation affecting pharmacogenes, particularly CYP450 enzymes, may contribute to altered parent-drug and metabolite concentrations and help explain unexpected toxicity or concentration patterns. However, genotype does not necessarily reflect functional metabolic activity because co-administered drugs, disease and environmental influences can produce phenoconversion. Drug-drug-gene interactions must therefore be considered alongside genetic findings. Practical implementation is additionally constrained by specimen quality, analytical and interpretative requirements, and the absence of standardised forensic-specific guidelines. Guidance on specimen collection and preservation, alongside emerging molecular and computational approaches, may support more reliable testing and individualised interpretation. PGx should not independently determine cause or manner of death, but may provide complementary information when integrated with toxicology, pathology, medical and prescription history, scene findings and postmortem factors.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149406318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Human factors in forensic toxicology: an exploratory international survey.","authors":"Hilary J Hamnett","doi":"10.1093/jat/bkag099","DOIUrl":"https://doi.org/10.1093/jat/bkag099","url":null,"abstract":"<p><p>Human factors, including cognitive biases and contextual effects are well-documented automatic processes that can influence forensic toxicology decisions. Research into aspects of human factors such as familiarity with concepts, use of bias-minimising procedures and the presence of laboratory policies is limited in forensic toxicology. Here, the results of an exploratory survey conducted at a forensic toxicology conference held in 2025reported. A group of participants attending the 62nd conference of The International Association of Forensic Toxicologists (TIAFT), which took place in Auckland, New Zealand from 23-27 November 2025, completed an online survey examining familiarity, training and use of bias-minimising procedures and policies. Fifty-one participants from 43 different countries and with a range of 1-50 years of experience volunteered. The results show that over three-quarters of respondents were familiar with human factors/cognitive bias, but that just over half of the respondents had received training on this topic, indicating that more training is needed. Laboratory policies on cognitive bias/human factors are also still relatively rare, with only a third of respondents stating their workplace had one. Finally, although bias-minimising procedures suitable for forensic toxicology were reportedly only being used by around one-third of participants' laboratories, a range of procedures were suggested by the participants. These need to be considered by laboratories and incorporated into quality systems and profession-specific guidance.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149406319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Emergence of Etomidate in Singapore.","authors":"Ching Yee Fong, Hooi Yan Moy","doi":"10.1093/jat/bkag097","DOIUrl":"https://doi.org/10.1093/jat/bkag097","url":null,"abstract":"<p><p>Etomidate is an ultrashort-acting, non-barbiturate sedative commonly used for hypnotic sedation and clinical anaesthesia. However, it can produce euphoria effects and cause addiction when consumed in large quantities. Recently, etomidate has emerged as a substance of misuse in Asia, particularly through its illicit incorporation into vaping products and leading to severe health risks to users. Following the China's classification of etomidate as controlled drug on 1 October 2023, structural analogues such as metomidate, propoxate, butomidate and CF3-etomidate have emerged in the market as replacements. In Singapore, etomidate was first detected in 2024 in \"Kpods\" e-vaporizers. Between October 2024 and December 2025, etomidate was detected in 898 urine samples from suspected drug users, with approximately 41.9% of these urine samples contained etomidate as the only detected substance. This study aims to elucidate the etomidate use patterns through the detailed urinary analysis of individuals who use drugs.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Postmortem femoral venous blood concentrations, redistribution and toxicity of duloxetine.","authors":"Raimo A Ketola, Margareeta Häkkinen","doi":"10.1093/jat/bkag095","DOIUrl":"https://doi.org/10.1093/jat/bkag095","url":null,"abstract":"<p><p>Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is widely prescribed for depression, anxiety, neuropathic pain, and other chronic pain conditions. Its pharmacokinetics show substantial interindividual variability due to sex, age, smoking, and CYP2D6 metabolism. Postmortem (PM) interpretation is further complicated by unknown blood-to-plasma distribution and significant postmortem redistribution. This study analyzed duloxetine concentrations in 2006-2026 Finnish forensic cases (N = 798), including fatal poisonings, polysubstance intoxications, and incidental findings. The median PM concentration of femoral venous blood samples was 0.16 mg/L, close to the upper therapeutic range of clinical plasma samples, while the mean concentration (0.33 mg/L) was twice as high. Based on our studies and data from the literature, toxic concentrations began at approximately 0.6 mg/L and fatal concentrations at 1-2 mg/L. In 13 fatal duloxetine poisonings, concentrations ranged from 0.46 to 9 mg/L, representing suicides and accidental over-dosing. In cases with both antemortem (AM) and PM samples, PM levels were on average 110% higher, indicating slight redistribution. Drug-drug interactions involving CYP2D6 inhibitors or substrates were present in several cases but did not fully explain the highest duloxetine concentrations. These findings highlight the need for cautious interpretation of PM duloxetine levels, especially in polysubstance intoxications and in individuals with impaired metabolism.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149342280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiahui Wu, Hong Song, Peng Zhao, Xianxin Chen, Jian Zhang, Bingbin Zhu, Yilei Fan, Qing Shen, Haixing Wang
{"title":"Simultaneous determination of etomidate and its derivatives in wastewater with online SPE-HPLC-MS/MS.","authors":"Jiahui Wu, Hong Song, Peng Zhao, Xianxin Chen, Jian Zhang, Bingbin Zhu, Yilei Fan, Qing Shen, Haixing Wang","doi":"10.1093/jat/bkag094","DOIUrl":"https://doi.org/10.1093/jat/bkag094","url":null,"abstract":"<p><p>Etomidate (ETM), a short-acting intravenous sedative, has been increasingly abused, particularly among young people in China and other parts of East Asia, leading to severe health issues and prompting regulatory control. Along with the control of ETM, several new ETM derivatives have emerged as substitutes. High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) is a widely used analytical technique for identifying and quantifying abused substances in wastewater, which faces challenges due to low analyte concentrations and matrix interference. This study introduces an online solid-phase extraction (SPE)-HPLC-MS/MS method for the simultaneous determination of ETM, its major metabolite etomidate acid, and eight ETM derivatives in wastewater. The HPLC-MS/MS conditions, including column selection, mobile phase composition, and sample pretreatment conditions, were optimized, respectively. Method validation demonstrated excellent linearity across calibration ranges of 1 to 1000 ng L-1, with limits of detection (LOD) and limits of quantification (LOQ) ranging from 0.2 to 3 ng L-1 and 1 to 10 ng L-1, respectively. The method exhibited satisfactory accuracy with recovery values ranging from 86.6% to 108.6%, and high precision with relative standard deviations between 4.8% and 13.9%. The validated method was successfully applied to analyze 40 authentic wastewater samples, of which four tested positive. The detected compounds included ETM (8.2 and 13.4 ng L-1 in two samples), metomidate (MEM) (6.8 ng L-1), and isopropoxate (IPX) (14.5 ng L-1). These findings make the method suitable for accurate and rapid monitoring of ETM and its derivatives in wastewater, providing a robust analytical tool for future wastewater-based epidemiology investigations.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149286815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Development and Validation of an Oral Fluid LC-MS/MS Method for Screening Emerging Synthetic Opioids Including Fentanyl Analogues, Nitazenes, and Xylazine.","authors":"Chara Parpala, Sotirios Toskos, Christina Matiaki, Evdokia Brousa, Heleni Zaggelidou, Nikolaos Raikos, Orthodoxia Mastrogianni","doi":"10.1093/jat/bkag091","DOIUrl":"https://doi.org/10.1093/jat/bkag091","url":null,"abstract":"<p><p>The emergence of highly potent synthetic opioids, including fentanyl analogues, nitazenes, and xylazine-associated drug mixtures, has created significant analytical challenges for forensic and toxicological laboratories. The aim of this study was to develop and validate a qualitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the screening of emerging synthetic opioids in oral fluid. Sample preparation was based on direct extraction of paper swabs with 500 μL of methanol containing 1% formic acid, followed by vortex mixing, ultrasonication, centrifugation, and direct LC-MS/MS analysis without evaporation or reconstitution. Method validation included selectivity and specificity, detection capability, matrix effects, inter-individual matrix variability, processed-sample stability, carryover, and intra-day precision. All target analytes fulfilled the established identification criteria at 1 ng/mL, the lowest concentration evaluated. Intra-day precision was acceptable, with RSD values ranging from 0.6% to 14.8%. Matrix effects were within 80-120% for the majority of analytes at both evaluated concentration levels, although compound-dependent ion suppression or enhancement was observed. Processed samples met the predefined stability criterion for 48 h at 4 °C and 72 h at - 20 °C, and carryover remained below the predefined acceptance criterion. Limited inter-individual variability was observed among the five donor matrices for the subset of analytes evaluated. The developed method provides a simple qualitative screening approach for an expanded panel of emerging synthetic opioids in oral fluid. Evaluation using authentic positive specimens is required to further establish its performance in forensic and DUID applications.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Munchelou M Gomonit, Sara E Walton, Michael T Truver, Chris W Chronister, Donna M Papsun, Alex J Krotulski, Bruce A Goldberger, Barry K Logan
{"title":"Intoxications and fatalities associated with the ingestion of the novel synthetic cathinone, N-isopropyl butylone.","authors":"Munchelou M Gomonit, Sara E Walton, Michael T Truver, Chris W Chronister, Donna M Papsun, Alex J Krotulski, Bruce A Goldberger, Barry K Logan","doi":"10.1093/jat/bkag079","DOIUrl":"10.1093/jat/bkag079","url":null,"abstract":"<p><p>Synthetic cathinones represent an expanding class of novel psychoactive substances (NPS), with their proliferation largely driven by international drug control measures and the rapid cycling of structural analogues designed to circumvent legislative scheduling. Following the international control of N, N-dimethylpentylone (DMP) in 2024, N-isopropyl butylone (NiPB) was increasingly detected in forensic toxicological casework as the prevalence of DMP declined. However, limited data currently exist regarding NiPB's concentration ranges in forensic investigations. This report describes a validated liquid chromatography-tandem quadrupole mass spectrometry (LC-QQQ-MS) method for the quantitation of NiPB in biological specimens, which was applied to the analysis of drugged driving (n = 1) and postmortem (n = 15) cases. The driving under the influence of drugs case yielded a NiPB blood concentration of 16 ng/mL, whereas the remaining 15 cases demonstrated blood concentrations ranging from <1 to 1400 ng/mL. For one case, NiPB was quantitated in blood, vitreous fluid, and urine, with concentrations of 18, 17, and 2200 ng/mL, respectively. Polydrug use was observed for all cases and frequently involved fentanyl (75%), cocaine and/or methamphetamine (69%), other synthetic cathinones (25%), ethanol (31%), and additional NPS such as bromazolam (19%) and MDMB-4en-PINACA (13%). Concentrations overlapped between antemortem and postmortem cases and were comparable to those reported for structurally related beta-keto methylenedioxyamphetamines, suggesting that members of this analogue class may share similar patterns of use and toxicological profiles. Although NiPB was identified as a contributing factor in several fatalities, the lack of pharmacological and toxicological data limits further interpretation of measured concentrations and the extent of its contribution to these fatal outcomes. Additional studies incorporating paired central and peripheral blood specimens are warranted to better characterize potential postmortem redistribution and its impact on NiPB blood concentration interpretation. Overall, this case series addresses a critical literature gap on NiPB by providing analytical and interpretive data to support forensic laboratories as NiPB identifications increase within the evolving NPS stimulant market.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148955971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluating post-analytical stability of blood ethanol samples using headspace-GC-FID.","authors":"David Cook, Jarrad Wagner","doi":"10.1093/jat/bkag089","DOIUrl":"10.1093/jat/bkag089","url":null,"abstract":"<p><p>The analysis and determination of blood alcohol concentration (BAC) is a cornerstone test in forensic toxicology that is well researched. The purpose of this study was to determine the post-analytical stability of blood ethanol obtained from re-injected vials via Agilent dual-column headspace-gas chromatography-flame ionization detection (Headspace-GC-FID). Over 6 months and 22 individual batch analyses, 303 samples were prepared and analyzed using headspace-GC-FID for the presence of blood ethanol using 0.02% n-propanol as an internal standard. Each individual batch was re-injected after storage at room temperature for 72 hours to mimic a typical weekend absence. Ethanol signal response, n-propanol signal response, and measured blood ethanol concentration were evaluated for stability in terms of percent change. The sample population consisted of negative human blood fortified with known concentrations of ethanol via certified reference material purchased from accredited vendors (n = 187) in the form of calibrators and controls, as well as unknown post-mortem and ante-mortem blood samples submitted to the Nassau County Medical Examiner's (NCME) Office Department of Forensic Toxicology (n = 116). All samples were tested using similar conditions and an internal standard. Significant differences were observed in the signal response for both n-propanol (P < .001) and ethanol (P < .001) between the two test groups; however, there was a non-significant difference in measured BAC between the two groups t(302) = 0.3, P = .780, d = 0.016. Results suggest very little effect of re-injection after 72-hour storage at room temperature on measured blood ethanol concentration using headspace GC-FID. While there was significant loss of ethanol and internal standard on reinjection, the calculated ethanol concentration was unaffected due to the similar properties of both volatile measurands as well as the consistency of the response ratio of ethanol: n-propanol in reinjected vials. In addition, the observed differences in measured BAC on re-injection were well within the NCME's measurement uncertainty of 11% at k = 3.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149136650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Detection and quantification of carbon monoxide in postmortem liver tissues via headspace GC-MS as an alternative to blood.","authors":"Aracelis A Velez, Rebecca A Phipps","doi":"10.1093/jat/bkag076","DOIUrl":"10.1093/jat/bkag076","url":null,"abstract":"<p><p>Carbon monoxide (CO) is a gas that is readily absorbed by the lungs when inhaled. Once in the blood, it forms a complex with hemoglobin (Hb) in red blood cells known as carboxyhemoglobin (COHb), reducing the oxygen-carrying capacity of Hb and therefore disrupting the transport and delivery of oxygen throughout the body. The resulting lack of oxygen can be harmful and even lethal, making it important to be able to detect COHb in postmortem samples of relevant cases for determining a cause of death. Blood and spleen are the preferred specimens for the detection of CO because they are Hb rich, but these specimens may not always be available for collection during autopsy. This study aims to determine if liver tissue can be a reliable source for the detection and/or quantification of CO in postmortem specimens in the absence of blood or spleen. Liver homogenates and blood specimens from 25 postmortem cases with a positive CO result in blood (%COHb ≥10%) and 10 postmortem cases testing negative for CO in blood (%COHb <10%) were analyzed for COHb via headspace gas chromatography/mass spectrometry (HS-GC/MS) and compared. Cases for which the blood produced a positive result for CO did not always result in a positive finding in the liver (%COHb ≥10%), even in cases with high levels of %COHb saturation (>50%). However, all cases that had a liver result ≥10% COHb had a corresponding blood result ≥10% COHb. If blood or spleen is not available for CO testing, liver may be tested as a potential indicator of CO exposure. A positive %COHb finding in the liver is a reliable indicator of a positive %COHb result in blood, but negative results in liver are inconclusive and cannot rule out CO exposure.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148891553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sophia Krombholz, Yiannis A Angelis, Gregor Fußhöller, Mario Thevis
{"title":"Urinary detection and metabolite profiles of trenbolone and metenolone following trace-level dermal exposure.","authors":"Sophia Krombholz, Yiannis A Angelis, Gregor Fußhöller, Mario Thevis","doi":"10.1093/jat/bkag085","DOIUrl":"10.1093/jat/bkag085","url":null,"abstract":"<p><p>Recent studies have demonstrated that dermal exposure to anabolic androgenic steroids (AAS) can result in adverse analytical findings (AAFs) in doping controls with a comparably long detectability of the parent compound and/or their metabolites in urine samples. Transdermal absorption is influenced by multiple factors, including physicochemical properties of the substance and solubility; but is largely driven by the degree of exposure, i.e. amount of substance applied. Therefore, this study aimed to investigate the detectability and urinary excretion profiles of trenbolone (TREN) and metenolone (MET) after dermal exposure to microgram quantities of these frequently abused AAS. Controlled excretion studies were conducted with healthy male volunteers, and each participant received a single dose of 50 µg TREN or MET via dermal application to the forearm. Urine samples were collected and analyzed for the parent compounds and their metabolites by liquid chromatography coupled to high resolution tandem mass spectrometry (LC-HRMS/MS). To enhance sensitivity and product ion formation, derivatization with Girard's reagent T was employed for MET and its metabolites. Following administration of transdermal microdoses, both substances and/or their metabolites were detectable in the urine samples of all participants. For TREN, predominantly the established main metabolite epitrenbolone was identified, with maximum concentrations up to 2.6 ng/ml and a detection window of up to 3 days post-application. Maximum concentrations of MET ranged from 0.1 to 1.2 ng/ml. Notably, particularly the sulfoconjugated metabolite of MET remained detectable for over a week in one volunteer. Metabolite profiles were compared with those of urine samples obtained after oral administration of the steroids to assess potential differences. Considering the increasing number of alleged transdermal contamination cases, the results provide important analytical data to better assess the plausibility of such claims.</p>","PeriodicalId":14905,"journal":{"name":"Journal of analytical toxicology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148989723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}